Condition
Urinary Urgency Incontinence
Total Trials
4
Recruiting
2
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Recruiting2
Completed1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06511141Not ApplicableRecruiting
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NCT07144813Not ApplicableRecruitingPrimary
Post-Approval Study of the Neuspera Sacral Neuromodulation System
NCT04232696Not ApplicableActive Not RecruitingPrimary
Neuspera's Implantable Sacral Nerve Stimulation System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)
NCT01843543Not ApplicableCompletedPrimary
Examining Bladder Control Using Mindful Based Approach
Showing all 4 trials